330793-38-9

Usage

Uses

4-Bromo-2-methoxybenzonitrile is a useful intermediate for organic synthesis.

InChI:InChI=1/C8H6BrNO/c1-11-8-4-7(9)3-2-6(8)5-10/h2-4H,1H3

Upstream product

• 865-33-8 potassium methanolate 
• 105942-08-3 4-bromo-6-fluorobenzonitrile 
• 124-41-4 sodium methylate 
• 67-56-1 methanol 
• 812667-44-0 4-bromo-2-methoxybenzamide 
• 141-52-6 sodium ethanolate 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 
• 5213-16-1 4-bromo-2-methoxybenzoyl chloride 
• 623-00-7 4-bromobenzenecarbonitrile 

Downstream Products

• 288067-35-6 4-bromo-2-hydroxy-benzonitrile 
• 677777-45-6 4-cyano-3-methoxyphenylboronic acid 
• 43192-33-2 4-bromo-2-methoxybenzaldehyde 
• 1018326-11-8 4-(4-(2-(4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetyl)piperidin-1-yl)-2-methoxybenzonitrile 
• 1100508-57-3 2-methoxy-4-([1-(([(4S)-4-methyl-2,5-dioxoimidazolidin-4-yl]methyl)sulfonyl)-1,2,3,6-tetrahydropyridin-4-yl]ethynyl)benzonitrile 
• 812667-44-0 4-bromo-2-methoxybenzamide 
• 1255207-18-1 2-(methyloxy)-4-prop-2-en-1-ylbenzonitrile 
• 1428477-93-3 2-methoxy-4-(2-{4-[2-(1-oxo-1,3-dihydro-2-benzofuran-5-yl)ethyl]piperidin-1-yl}ethyl)benzonitrile 
• 84224-29-3 4-hydroxy-2-methoxybenzonitrile 
• 1255207-15-8 2-(methyloxy)-4-(2-oxoethyl)benzonitrile 
• 1255869-19-2 N-((5-(4-cyano-3-methoxyphenyl)pyridin-3-yl)methyl)methanesulfonamide 
• 1308668-83-8 4-[4-((S)-1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308668-81-6 4-[4-((R)-1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 
• 1308668-80-5 4-[4-(1-hydroxy-ethyl)-pyridin-3-yl]-2-methoxy-benzonitrile 

Relevant academic research and scientific papers

NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF

The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit

Aminopyridyloxypyrazole derivative and preparation method and application thereof

The invention relates to an aminopyridyloxypyrazole derivative and a preparation method and application thereof. The structure of the aminopyridyloxypyrazole derivative is shown as a formula (I). The invention provides a brand-new aminopyridyloxypyrazole derivative which has obvious effects of inhibiting TGF [beta] R1 (ALK5) kinase activity and treating cancer or fibrosis related diseases, and the preparation method of the derivative is simple and easy to operate.

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

The present invention is directed to substituted indole compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, adisease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

Pd(OAc)2-catalyzed alkoxylation of arylnitriles via sp 2 C-H bond activation using cyano as the directing group

A Pd(OAc)2-catalyzed ortho-alkoxylation of arylnitrile was described. Using cyano as a directing group, the aromatic C-H bond can be functionalized efficiently to generate ortho-alkoxylated arylnitrile derivatives with moderate yields. The opti

4, 5-DIHYDRO-LH-PYRAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USES

Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.

NOVEL COMPOUNDS

The invention provides novel hydantoin derivatives; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.

CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present application describes modulators of MIP-1α of formula (I), or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein n, A, T, R1, R2 and R8, are as defined herein. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using the modulators of formula (I) are disclosed.

Piperazine Heteroaryl Derivatives as Gpr38 Agonists

The invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, Z, X and B are as defined in the specification. The compounds are partial or full agonists at the GPR38 receptor. Pharmaceutical compositions comprising the compounds, methods of preparing the compounds, uses of the compounds and methods involving the compounds are also provided.

BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF CANCERS OF THE CENTRAL NERVOUS SYSTEM

The present invention relates to benzofuran and benzothiophene derivatives and compositions containing such compounds for the production of medicaments for the treatment of cancers of the central nervous system as monotherapy or combination with other agents.

PIPERAZINE HETEROARYL DERIVATES AS GPR38 AGONISTS

The invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof, (I) wherein R1, R2, R3, R4, R5, R6, Z, X and B are as defined in the specification. The compounds are partial or full agonists at the GPR38 receptor. Pharmaceutical compositions comprising the compounds, methods of preparing the compounds, uses of the compounds and methods involving the compounds are also provided.